People: China Nepstar Chain Drugstore Ltd (NPD)

NPD on New York Consolidated

1.85USD
22 Oct 2014
Price Change (% chg)

$0.01 (+0.54%)
Prev Close
$1.84
Open
$1.88
Day's High
$1.88
Day's Low
$1.85
Volume
871
Avg. Vol
49,263
52-wk High
$3.49
52-wk Low
$1.53

Search Stocks

Summary

Name Age Since Current Position

Simin Zhang

51 1995 Chairman of the Board

Fuxiang Zhang

40 2011 Chief Executive Officer

Zixin Shao

44 2010 Chief Financial Officer

Henry Lu

48 2014 Director

Barry Buttifant

68 2007 Independent Director

Alistair Laband

61 2007 Independent Director

Biographies

Name Description

Simin Zhang

Dr. Simin Zhang is Chairman of the Board of China Nepstar Chain Drugstore Ltd., since June 1995. Mr. Zhang is also the chairman of the board of directors of the Neptunus Group. Prior to founding the Neptunus Group in July 1989, he was an employee in CITIC Group from 1986 to 1989. From 1983 to 1986, he was an employee in the PRC Space Administration. He is currently a guest professor at the Harbin Institute of Technology and Jilin University, an executive director of China Enterprise Confederation and China Enterprise Directors Association and the president of Shenzhen General Chamber of Commerce. Mr. Zhang received a bachelor’s degree in precision instruments from Harbin Institute of Technology in 1983, an honorary doctorate from University of Newcastle in Australia in 1997 and a Ph.D. degree in economics from Nan Kai University in 2001.

Fuxiang Zhang

Mr. Fuxiang Zhang serves as Chief Executive Officer of China Nepstar Chain Drugstore Ltd. Mr. Zhang joined our company in 1997 and served as our vice president from 2006 to 2011 and then as our chief operating officer from March 2011 until his promotion in August 2011. From 2003 to 2006, Mr. Zhang served as the general manager of Shenzhen Nepstar Group Co., Ltd., one of our regional Nepstar companies. From 1999 to 2003, he was the vice general manager and then promoted to general manager of Nepstar Dalian. Mr. Zhang received a bachelor’s degree in international economics in 1997 and a master’s degree in industrial engineering in 2010 from the Harbin Institute of Technology.

Zixin Shao

Mr. Zixin Shao is Chief Financial Officer of China Nepstar Chain Drugstore Ltd., since November 2010. Mr. Shao joined our company in 2003 and has served as financial controller for our company since then. Prior to joining our company, he worked as a director, vice general manager and chief financial officer in China Resources Supermarket (Suzhou) Co., Ltd. from 1999 to 2001. From 1992 to 2002, he also held financial management position at China Resources Supermarket (HK) Co., Ltd. Mr. Shao received a bachelor’s degree in accounting from the University of International Business and Economics in China in 1992. Mr. Shao is a PRC certified accountant.

Henry Lu

Dr. Henry Lu is Director of the Company. Dr. Lu has been Director of Capital Eagle Global Limited since May 2014 and Managing Director of China Merchants Capital since February 2014. Dr. Lu was Partner of SVC China from 2012 to 2014 and Chief Representative of William Blair & Company, L.L.C., Shanghai Representative Office from 2006 to 2011. Prior to that, Dr. Lu was with McKinsey & Company advising global and domestic companies on their growth and financial strategies. Dr. Lu received a PhD from Columbia University in 1997 and an MBA from University of Chicago Business School in 2000.

Barry Buttifant

Mr. Barry J. Buttifant, CPA, is Independent Director of China Nepstar Chain Drugstore Ltd., since November 2007. He is a member of our audit committee, compensation committee, corporate governance and nominating committee. He is an independent non-executive director of Daiwa Associate Holdings Limited and Giordano International Limited, and a non-executive director of Synergis Holdings Limited (‘Synergis’), all of which are publicly listed companies in Hong Kong. Dr. Buttifant also serves as a non-executive director of Global-Tech Advanced Innovations Inc., a NASDAQ listed company. Dr. Buttifant is currently an executive director of Hsin Chong Construction Group Ltd (‘HCCG’). Prior to that, he was group chief executive officer of IDT International Limited. In October 2009, Dr. Buttifant rejoined Mission Hills Group (‘MHG’), as a Director — Corporate Finance. Prior to this appointment, he was a consultant to the MHG since December 2008. Prior to joining MHG, he served as a Principal to KLC Kennic Lui & Company (‘KLC’). Prior joining KLC, Dr. Buttifant was the Executive Director — Finance of the MHG. In December 2004, he was the managing director of Hsin Chong International Holdings Limited. Dr. Buttifant was also an alternate director to both HCCG and Synergis. Dr. Buttifant was an operating partner of Barings Private Equity Asia Limited. He was also the managing director of Wo Kee Hong (Holdings) Limited (‘WKH’), from 2001 to 2002 and was the advisor to the board of directors of WKH from 2002 to 2004. Prior to joining WKH, he was the managing director of IDT International Limited. Dr. Buttifant is a fellow member of the Association of Chartered Certified Accountants; the Hong Kong Institute of Certified Public Accountants; the Chartered Management Institute; the Hong Kong Management Association and the Hong Kong Institute of Directors. He has been awarded an honorary doctorate of Business Administration (honoris causa) by Edinburgh Napier University, United Kingdom.

Alistair Laband

Mr. Alistair Eric MacCallum Laband serves as Independent Director of China Nepstar Chain Drugstore Ltd., since November 2007. Mr. Laband is a member of our audit committee, our compensation committee and corporate governance and nominating committee. From November 2008 until the end of March 2011 Mr. Laband was a financial consultant to CITIC Pacific Ltd., a company listed on the Hong Kong Stock Exchange. From 2003 to June 2007, he was a partner of PricewaterhouseCoopers, or PwC, Hong Kong/China and until March 2007, secretary of the PwC Asia Region Board. From 2001 to 2002, he was a partner in charge of the Company Secretarial Services Group of PwC’s Hong Kong office. From 1997 to 2001, he was finance/operations partner and a management board member of the Hong Kong office of Price Waterhouse, or PW, and subsequently, the Hong Kong office of PwC. From 1997 to 1998, he was also in charge of the company secretarial and legal services group of PW’s Hong Kong office. Mr. Laband obtained a bachelor’s degree in law from the University of Cambridge in 1973 and a diploma in accountancy from the University of Strathclyde in 1976. Mr. Laband is a Chartered Accountant of the Institute of Chartered Accountants of Scotland and a Fellow of the Institute of Certified Public Accountants of Hong Kong.

Basic Compensation

Name Fiscal Year Total

Simin Zhang

--

Fuxiang Zhang

--

Zixin Shao

--

Henry Lu

--

Barry Buttifant

--

Alistair Laband

--
As Of 

Options Compensation

Search Stocks